Skip to main content

Rebirth


Six years ago, I wrote the first post on this blog, in anticipation of the arrival of our son, Asa.

In addition to the excitement of impending fatherhood, I was inspired by two members of my family who’d blogged.

Seth, a cousin, had written a blog about his son Tofu. When Seth died midway through Tofu’s second year of life, the blog became a sort of message in a bottle, a testament of his love for his child. 

The other inspiration was my aunt Anne. Her blog helped her friends and family – spread quite widely across the world – stay informed about her battle with cancer.

This month we welcomed into our family a baby girl, whom we’ve named after Anne.

Anne (nickname Ayya) at 3 weeks old, on Christmas Day


At birth baby Anne weighed in at just over 3 kilos (6 lb, 7 oz). She's a small package. But she changes the balance of our family, shifts the fulcrum. From being two adults and a child (adults holding the majority), we now have equal representation from children.

Asa and I, as males, are preparing ourselves for the impacts of a second female in the house.

Resolution


She also represents a challenge for this blog, which began as a vehicle for my wonder at Asa’s presence in the world. The blog then morphed into a kind of cancer diary; and hasn’t known quite what to do with itself since.

I’m way overdue, for example, in relating the transition we’ve made from the days when Asa was in hospital every 3 weeks, and getting treated every time … to the current regime of 2-monthly exams, the purpose of which is mainly to check we’re still in remission. It’s a very different place.

Maybe it would have been a challenge to keep the blog going anyhow. As children move from toddlerhood to school age ... life gets complicated. At least it did for us. 

Then again, we've only ever done this once.

But -- Anne, here I'm talking to you -- we feel you've arrived at a good time. Asa and the rest of us are ready to do our kindred duties.

As part of mine (I must admit the more practical matters rest largely on Selam’s shoulders) I want to enlarge and revive this blog.

Just as you are enlarging our family, and giving us new life.


Happy new year / Melkam addis amet


Comments

  1. Asa, Selam and Jed, please receive my heartfelt congratulations to you. Surely, the Princess will shine your family brighter. May the new year bring to you more blessings and joy. The blog is so strong, glad to hear that it will grow further.

    ReplyDelete
  2. Thank you, Abiy! Blessings to you and your family, from all of us.

    ReplyDelete
  3. I'm so happy for you Jed! I'm in the midst of preparing content for a blog about letting go, memory, sharing - all around mum's wedding dress. I'll keep you posted - maybe Ayya-Anne will wear it someday!
    XXX love m

    ReplyDelete
    Replies
    1. Looking forward to reading that blog, Miriam. I love the idea of the wedding dress being used for another generation. That's a particularly beautiful kind of hand-me-down.

      Delete
  4. So happy for you all! Congratulations and look forward to more updates!!❤

    ReplyDelete
  5. Would be cool to have a blog entry about how Asa likes his baby sister. (Hint hint)

    ReplyDelete

Post a Comment

Popular posts from this blog

Mixed results

Last Wednesday Asa was put to sleep and underwent an eye exam under anaesthetic. 
The first since the beginning of the new chemo, the exam showed that the drugs have had a "partial effect."


In Asa's left eye, the tumours responded well to the chemo. 
But in the right eye, there's been a slight increase in tumour activity.
And in the left eye there's a cataract developing.
A mixed bag
This was not what we'd hoped to hear.
We had reason to expect that the TVD (topotecan-vincristine-doxorubicin) combination would lead to shrinkage of the tumours in both eyes. 
And the appearance of a cataract -- a clouding of the lens -- at this stage is unusual: puzzling to the doctors as well as us.
While cataracts can be removed through surgery, cutting into the eye when there are active tumours inside is not advisable. So treatment for the cataract itself will have to wait until the tumours are stable.
The main risk in the near future is that the cataract may make it difficult to moni…

Hard questions

One morning recently, when we were trying to get Asa to put on his socks, he asked us, seemingly out of nowhere: “What does it have in it, my right eye?” It was clear he wasn’t in discomfort; it wasn’t that he had a piece of grit in there. He pointed up at his eye with his index finger.
“Well, it’s got jelly in it,” I said. “And a retina, and a lens. And lots of other things we didn’t know about two years ago.” “And what does it have in it, my left eye? Does it have a lens?” “No, your left eye doesn’t have a lens.” “What happened to it, the lens?” “The doctor took it out, because the eye was poorly.” “Was the lens poorly?” It had gotten --” “Cloudy,” Selam offered. “Yes, it had gotten all cloudy, and you couldn't see well through it. So he took it out.” “Who took it out?”  “The doctor took it out.” “It doesn’t have any lens.” “No. That’s why you have to wear glasses sometimes, so you can see better. And that’s why Mummy patches your right eye sometimes. Because we want you to see as well as …

Relapse. Birthday.

Wednesday'sExamination Under Anaesthetic yielded some unexpected news.
In Asa's left eye, which had been stable since the end of primary chemo in June, there were 4 or 5 new tumours, and one previously treated tumour that was growing slowly. There were also some new seeds.
In his right eye, moreover, the tumours that had earlier responded well to Melphalan had started to relapse.
These areas are at the front of the eye -- as the doctor put it, "almost where the retina finishes."
And the seeds that were there last time had not responded to the cryotherapy.


Treatment options
When Selam picked Asa up from the recovery room, both of his eyes were red and swollen from cryotherapy.
Cryo is a stop-gap measure: Since too much of it can cause retinal detachment, this approach doesn't hold much promise for controlling the tumour growth in the long term.
The area of tumour activity is also too wide for the more gentle kinds of radiotherapy -- such as radiation delivered through a …